Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (Q73903671)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 2003

Language	Label	Description	Also known as
English	Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system	scientific article published on 01 September 2003

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

myocardial infarction

1 reference

based on heuristic

inferred from title

Francisco España

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Esther Zorio

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Remedios Castelló

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Cristina Falcó

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Ana Osa

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Luis Almenar

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Justo Aznar

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Amparo Estellés

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

British Journal of Haematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

122

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

958-965

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Inducible carboxypeptidase activity. A role in clot lysis in vivo

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04549.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2003.04549.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12956767%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73903671&oldid=1751102180"